Ecosystem allies
Strategic partnerships accelerating your path to the clinic
Our ecosystem enables partners to advance from discovery to clinic faster
Building the most efficient companies with a unique venture approach
Creating asset centric drug companies with incredible capital efficiency by leveraging the platforms and services of Alloy Therapeutics.
Advancing programs from candidate into the clinic with expertise and efficiency
Spannerwerks provides hands-on development support across core drug development functions, helping biotech teams execute with focus, flexibility, and confidence through early development milestones.
Ecosystem allies uniting to advance drug discovery from concept to clinic
Advance the development of your discovered drugs
Wheeler Bio’s modular CMC approach accelerates the transition from discovery to IND. Under Wheeler’s PhaseTM offering, Alloy partners can receive preferred services including a seamless transition from discovery to IND, reduced initial payment, and dollar-for-dollar reductions in Alloy commercial milestones.
Advancing programs from candidate into the clinic with expertise and efficiency
Through its network of expert resources, Spannerwerks enables companies to rapidly and efficiently advance through key value-inflection points in preclinical and early clinical development without the need to build a full internal team. With expertise across integrated program management, CMC, regulatory, clinical operations, and related disciplines, Spannerwerks delivers the right support at the right time.
Become part of the ecosystem
Latest News and Resources
